Fluorescence pharmacokinetics of Lutetium Texaphyrin (PCI-0123, Lu-Tex) in the skin and in healthy and tumoral hamster cheek-pouch mucosa

Journal of Photochemistry and Photobiology B: Biology

Volumn 55, Issue 1, 2000, Pages 56-62

  Zellweger, Matthieu ^a   Radu, Alexandre ^b   Monnier, Philippe ^b   Van Den Bergh, Hubert ^a   Wagnières, Georges ^a  

^a EPFL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Fluorescence spectroscopy; Hamster cheek pouch mucosa; Lutetium Texaphyrin (Lu Tex, PCI 0123)

Indexed keywords

LUTETIUM; LUTETIUM TEXAPHYRIN; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; HAMSTER; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TIME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CRICETINAE; MALE; MESOCRICETUS; METALLOPORPHYRINS; MICROSCOPY, FLUORESCENCE; MOUTH MUCOSA; MOUTH NEOPLASMS; PHOTOSENSITIZING AGENTS; SKIN; SUNLIGHT;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0034073780     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(00)00027-0     Document Type: Article

References (35)

1. G. Jori, C. Perria, Photodiagnosis and phototherapeutic techniques in medicine, Documento Editoriale, Milan, Italy, 1995.
2. Schuitmaker J.J., Baas P., van Leengoed H.L.L.M., van den Muelen F.W., Star W., van Zandwijk N. Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol. B: Biol. 34:1996;3-12.
3. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90(12):1998;889-905.
4. Stables G.I., Ash D.V. Photodynamic therapy. Cancer Treatment Revs. 21(4):1995;311-323.
5. Edell E.S., Cortese D.A. Photodynamic therapy: its use in the management of bronchogenic carcinoma. Clin. Chest Med. 16(3):1995;455-463.
6. Henderson B.W., Dougherty T.J. How does photodynamic therapy work. Photochem. Photobiol. 55:1992;145-157.
7. Grosjean P., Wagnières G., Fontolliet C., van den Bergh H., Monnier Ph. Clinical photodynamic therapy for superficial cancer in the esophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br. J. Cancer. 77(11):1998;1989-1995.
8. Monnier Ph., Savary M., Fontolliet C., Wagnières G., Châtelain A., Cornaz P., Depeursinge C., van den Bergh H. Photodetection and photodynamic therapy of 'early' squamous cell carcinomas of the pharynx, esophagus and tracheo-bronchial tree. Lasers Med. Sci. 5:1990;149-169.
9. Sutedja T., Postmus P. Photodynamic therapy in lung cancer. A review. J. Photochem. Photobiol. B: Biol. 36:1996;199-204.
10. Hayata Y., Kato H., Furuse K., Kusunoki Y., Suzuki S., Mimura S. Photodynamic therapy of 168 early stage cancers of the lung and oesophagus: a Japanese multi-centre study. Lasers Med. Sci. 11:1996;255-259.
11. Kato H. Photodynamic therapy for lung cancer - a review of 19 years' experience. J. Photochem. Photobiol. B: Biol. 42:1998;96-99.
12. Radu A., Grosjean P., Fontolliet Ch., Wagnières G., Woodtli A., Van den Bergh H., Monnier Ph. Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus and the bronchi: a single-institution experience. Diagnost. Therapeut. Endoscopy. 5:1999;145-154.
13. Koderhold G., Jindra R., Koren H., Alth G., Schenk G. Experiences of photodynamic therapy in dermatology. J. Photochem. Photobiol. B: Biol. 36:1996;221-223.
14. Szeimies R.-M., Calzavara-Pinton P., Karrer S., Ortel B., Landthaler M. Topical photodynamic therapy in dermatology. J. Photochem. Photobiol. B: Biol. 36:1996;213-219.
15. Grosjean P., Savary J.-F., Mizeret J., Wagnières G., Woodtli A., Theumann J.-F., Fontolliet C., van den Bergh H., Monnier Ph. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin. J. Clin. Laser Med. Surg. 14(5):1996;281-287.
16. Grosjean P., Savary J.-F., Wagnières G., Mizeret J., Woodtli A., Theumann J.-F., Fontolliet C., van den Bergh H., Monnier Ph. Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers. Lasers Med. Sci. 11:1996;227-235.
17. Dilkes M.G., DeJode M.L., Rowntree-Taylor A., McGilligan J.A., Kenyon G.S., McKelvie P. m-THPC photodynamic therapy for head and neck cancer. Lasers Med. Sci. 11:1996;23-29.
18. Ma L., Moan J., Berg K. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int. J. Cancer. 57:1994;883-888.
19. Fan K., Hopper C., Speight P., Bown S. Photodynamic therapy using a new photosensitizer, mTHPC, in the treatment of oral cancer. J. Dental Res. 75(5):1996;1164-1164.
20. Fan K.F.M., Hopper C., Speight P.M., Buonaccorsi G.A., Bown S.G. Photodynamic therapy using mTHPC for malignant disease in the oral cavity. Int. J. Cancer. 73(1):1997;25-32.
21. Ris H.B., Altermatt H.J., Nachbur B., Stewart C.M., Wang Q., Lim C.K., Bonnett R., Althaus U. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg. Med. 18(1):1996;39-45.
22. Wagnières G., Hadjur Ch., Grosjean P., Braichotte D., Savary J.-F., Monnier Ph., van den Bergh H. Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin. Photochem. Photobiol. 68(3):1998;382-387.
23. Bonnett R. New photosensitisers for the photodynamic therapy of tumours. Proc. SPIE. 2078:1994;74-90.
24. Mody T.D., Wright M., Linquist V., Young S.W., Sessler J.L., Harriman A., Berns M., Miller R.A. Lutetium (III) texaphyrin: a novel photodynamic therapy agent. Photochem. Photobiol. 59S:1994;37S.
25. Young S.W., Woodburn K.W., Wright M., Mody T.D., Fan Q., Sessler J.L., Dow W.C., Miller R.A. Lutetium Texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem. Photobiol. 63(6):1996;892-897.
26. Woodburn K.W., Fan Q., Miles D.R., Kessel D., Luo Y., Young S.W. Localization and efficacy analysis of the phototherapeutic Lutetium Texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Photochem. Photobiol. 65(3):1997;410-415.
27. Kostenich G., Orenstein A., Roitman L., Malik Z., Ehrenberg B. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system. J. Photochem. Photobiol. B: Biol. 63:1997;36-42.
28. Andrejevic S., Savary J.-F., Fontolliet Ch., Monnier Ph., van den Bergh H. 7,12-Dimethylbenz[a]anthracene-induced 'early' squamous cell carcinoma in the Golden Syrian hamster: evaluation of an animal model and comparison with 'early' forms of human squamous cell carcinoma in the upper aero-digestive tract. Int. J. Exp. Pathol. 77:1996;7-14.
29. Th. Glanzmann, M. Forrer, S. Andrejevic-Blant, A. Woodtli, P. Grosjean, D. Braichotte, H. van den Bergh, Ph. Monnier, G. Wagnières, Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model in comparison with its clinical counterpart, J. Photochem. Photobiol. B: Biol., in press.
30. Zellweger M., Grosjean P., Monnier Ph., van den Bergh H., Wagnières G. Fluorescence measurement of Foscan® in the human oral cavity to predict tissue damage induced by photodynamic therapy in the esophagus and the bronchi. Photochem. Photobiol. 69(5):1999;605-610.
31. Andrejevic S., Savary J.-F., Monnier Ph., Fontolliet C., Braichotte D., Wagnières G., van den Bergh H. Measurements by fluorescence microscopy of the time-dependent distribution of meso-tetra-hydroxyphenylchlorin in healthy tissues and chemically induced 'early' squamous cell carcinoma of the Syrian hamster cheek pouch. J. Photochem. Photobiol. B: Biol. 36:1996;143-151.
32. Braichotte D., Savary J.-F., Glanzmann Th., Westermann P., Folli S., Wagnières G., Monnier Ph., van den Bergh H. Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths. Int. J. Cancer. 63:1995;198-204.
33. Hammer-Wilson M., Ghahramanlou M., Berns M. Photodynamic activity of Lutetium-Texaphyrin in a mouse tumor system. Lasers Surg. Med. 24:1999;276-284.
34. T. Wieman, V. Fingar, S. Taber, M. Panjehpour, C. Julius, T. Panella, A. Yuen, S. Horning, K. Woodburn, J. Engel, R. Miller, M. Renschler, S. Young, Phase I photodynamic therapy trial with Lutetium-Texaphyrin (PCI-0123) in patients with metastatic cancer, 24th Annual Meet. Am. Soc. for Photobiology, Atlanta, GA, USA, June 1996.
35. Glanzmann Th., Hadjur Ch., Zellweger M., Grosjean P., Forrer M., Ballini J.-P., Monnier Ph., van den Bergh H., Chang K.L., Wagnières G. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy. Photochem. Photobiol. 67(5):1998;596-602.